- Home
- L vs PODD Comparison
L vs PODD Comparison
Compare L & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- L
- PODD
- Stock Information
- Founded
- L 1969
- PODD 2000
- Country
- L United States
- PODD United States
- Employees
- L N/A
- PODD N/A
- Industry
- L Property-Casualty Insurers
- PODD Medical/Dental Instruments
- Sector
- L Finance
- PODD Health Care
- Exchange
- L Nasdaq
- PODD Nasdaq
- Market Cap
- L 21.1B
- PODD 22.1B
- IPO Year
- L N/A
- PODD 2007
- Fundamental
- Price
- L $102.72
- PODD $320.10
- Analyst Decision
- L
- PODD Strong Buy
- Analyst Count
- L 0
- PODD 19
- Target Price
- L N/A
- PODD $345.42
- AVG Volume (30 Days)
- L 678.1K
- PODD 532.2K
- Earning Date
- L 11-03-2025
- PODD 11-06-2025
- Dividend Yield
- L 0.24%
- PODD N/A
- EPS Growth
- L N/A
- PODD N/A
- EPS
- L 6.86
- PODD 3.45
- Revenue
- L $18,266,000,000.00
- PODD $2,521,800,000.00
- Revenue This Year
- L N/A
- PODD $29.32
- Revenue Next Year
- L N/A
- PODD $18.37
- P/E Ratio
- L $14.82
- PODD $92.68
- Revenue Growth
- L 6.06
- PODD 27.11
- 52 Week Low
- L $78.98
- PODD $230.05
- 52 Week High
- L $103.52
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- L 64.20
- PODD 50.14
- Support Level
- L $98.15
- PODD $290.16
- Resistance Level
- L $102.00
- PODD $335.00
- Average True Range (ATR)
- L 1.44
- PODD 10.46
- MACD
- L 0.20
- PODD 0.04
- Stochastic Oscillator
- L 90.28
- PODD 66.39
About L Loews Corporation
Loews Corp is a holding company along with its subsidiary engaged in commercial property and casualty insurance, transportation and storage of natural gas and natural gas liquids, operation of a chain of hotels, and also in the manufacture of rigid plastic packaging solutions. It has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA Financial Corporation, Boardwalk Pipeline Partners, LP and Loews Hotels Holding Corporation; and the Corporate segment.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.